Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mycobacterial cell membrane is a vital component of the complex cell envelope that distinguishes the genus Mycobacterium, including Mycobacterium tuberculosis. It consists of a standard inner plasma membrane and a unique, highly impermeable outer membrane known as the mycomembrane, which is characterized by a high concentration of long-chain mycolic acids (Source [9]). This membrane system is essential for maintaining the bacterial proton motive force, managing nutrient and waste transport, and providing a defensive barrier against host immune responses and antibiotic penetration (Source [1, 2, 9]). Drugs targeting the mycobacterial cell membrane function, most notably the first-line antibiotic pyrazinamide, work by dissipating the transmembrane pH gradient or disrupting the proton motive force, particularly in the acidic environments of host macrophages (Source [10, 11]). Other therapeutic agents target specific membrane-bound proteins, such as the MmpL3 transporter (inhibited by SQ109) and ATP synthase (inhibited by bedaquiline), to lethal effect by disrupting structural integrity or energy production (Source [1, 2, 5]). Because of its unique lipid composition, the mycobacterial membrane offers significant opportunities for the development of selective anti-tubercular agents that can eradicate both actively dividing and non-replicating persister bacilli (Source [2, 6]).
Disruption of the transmembrane pH gradient and proton motive force, inhibition of membrane-bound transporters such as MmpL3, and interference with membrane-associated energy production like ATP synthesis (Source [1, 2, 10]).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial cell membrane.